Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2018.417 | Prevention of metacarpophalangeal joints structure damage in patients with psoriatic arthritis using tofacitinib | Prof. TAM Lai Shan |
| 2019.063 | Effects of tight-control strategy with rosuvastatin on progression of subclinical carotid and coronary atherosclerosis in psoriatic arthritis- a prospective cohort study |
Prof. TAM Lai Shan 譚麗珊 |
| 2018.225 | The APLAR Spondyloarthritis (SpA) Registry |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.573 | Subclinical gut inflammation and gut microbiome in axial spondyloarthritis patients in Hong Kong |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.401 | Immunological role of the ILC2-B lymphocyte regulatory axis in systemic lupus erythematosus |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.650 | Effects of tight-control strategy with and without rosuvastatin on progression of subclinical coronary and carotid atherosclerosis in psoriatic arthritis- a randomized placebo-controlled study |
Prof. TAM Lai Shan 譚麗珊 |
| 2026.275 | Investigating the presence of anti-citrullinated SR-A peptide antibodies as a novel biomarker for RA | Prof. TAM Lai Shan |
| 2026.229 | Prospective MRI and HR-pQCT Study of Subclinical Musculoskeletal Involvement in Psoriasis with Arthralgia and Progression to Psoriatic Arthritis | Prof. Tam Lai Shan |
| 2026.341 | A Phase 1, open-label, dose-escalation study (ELEVATE-1) to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of a CD19/CD20 T-cell engager in participants with B-cell driven autoimmune rheumatic diseases (ARD) | Prof. Tam Lai Shan |
| 2026.344 | Therapeutic strategy and remission of rheumatoid arthritis in the Asia-Pacific region - A multicenter real-world study | Prof. Tam Lai Shan |
| 2026.338 | Treat-to-target aiming at DORIS remission and progression of subclinical atherosclerosis in systemic lupus erythematosus: a 2-year prospective cohort using high-resolution carotid ultrasound |
Prof. TAM Lai Shan 譚麗珊 |
| 2026.407 | Incident comorbid cardiovascular disease in patients with rheumatoid arthritis | Prof. Tam Lai Shan |
| 2011.174 | A stochastic cost-effectiveness analysis of an early inflammatory arthritis clinic in Hong Kong | Prof. TAM Lai Shan |
| 2009.215 | In vivo assessment of bone microarchitecture in patients on chronic steroid therapy by high-resolution peripheral quantitative computed tomography and the finite method | Prof. Tam Lai Shan |
| 2011.031 | The role of HMGB1 in the pathogenesis of systemic lupus erythematosus | Professor TAM Lai Shan |
| 2008.475 | Innate pathogen recognition in systemic lupus erythematosus: Toll-like receptors and NOD-like receptors | Prof Tam Lai Shan |
| 2012.478 | Vascular effects of achieving minimal disease activity iin psoriatic arthritis - a 2 year prospetive cohort study | Prof. TAM Lai Shan |
| 2010.191 | Human Papillomavirus infection and cervical intraepithelial neoplasia in patients with systemic lupus erythematosus- the role of toll-like receptors | Prof. TAM Lai Shan |
| 2009.273 | Diagnostic and Prognostic Values of Anti-Ceclic Citullinated Peptide Antibodies in Chinese Population with Rheumatoid Arthritis | Prof. Tam Lai Shan |
| 2009.583 | Function and expression profile of the nucleotide-blinding and oligoerization domain (NOD)-2 receptors in systemic lupus erythematosus | Prof. Tam Lai Shan |
| 2010.455 | A prospective case-control cost of illness studies in systemic lupus erythematosus | Prof. Tam Lai Shan |
| 2011.228 | Effects of inflammation on bone loss in rheumatoid arthritis: Does inflammation affect joints and bone equally? | Prof. Tam Lai Shan |
| 2011.509 | In vivo assessment of periaricular and generalized bone loss in patients with rheumatoid arthritis by high resolution peripheral quantitative computed tomography | Prof. Tam Lai Shan |
| 2011.547 | The role of Receptor for Advanced Glycation End Products (RAGE) in the pathogenesis of systemic Lupus erythematosus (SLE) | Professor TAM Lai Shan |
| 2010.250 | HMGB1: a danger signal molecule of the innate immune response for the immunopathogenesis of systemic lupus erythematosus | Prof. TAM Lai Shan |
| 2011.570 | Bone quality in men with rheumatoid arthritis: A case-control study using the high-resolution peripheral quantitative computed tomography | Prof. TAM Lai Shan |
| 2025.247 | Arresting Enthesiophyte and Erosion Progression in PsA: A 5-Year HR-pQCT Study | Prof. TAM Lai Shan |
| 2024.221 | Evaluation of molecular and cellular dysregulation in systemic lupus erythematosus |
Prof. TAM Lai Shan 譚麗珊 |
| 2025.738 | Cardiovascular and neurocognitive benefit of disease modifying antirheumatic drugs in patients with rheumatoid arthritis and psoriatic arthritis in Hong Kong: A large population study | Prof. TAM Lai Shan |
| 2024.661 | Methotrexate versus TNF inhibition in preventing structural damage in Early Psoriatic Arthritis: A randomized trial using HR-pQCT (MeTEPsA trial) | Prof. TAM Lai Shan |
| 2025.264 | Identifying the optimal erosion volume threshold for predicting rheumatoid arthritis in individuals with arthralgia: a high-resolution peripheral quantitative computed tomography study | Prof. TAM Lai Shan |
| 2025.316 | Can biologic DMARD use retard syndesmophytes and facet joint arthritis progression and resolve axial inflammatory in psoriatic arthritis? A prospective follow up study using low-dose computed tomography and magnetic resonance imaging | Prof. TAM Lai Shan |
| 2024.352 | A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout |
Prof. TAM Lai Shan 譚麗珊 |
| 2025.244 | AI-Powered Decision-Making Model in Optimizing Belimumab and Telitacicept Treatment for SLE through Genetic and Immune Profiling |
Prof. TAM Lai Shan 譚麗珊 |
| 2024.718 | REMIPPSA: REMISSION STATUS IN PSORIATIC ARTHRITIS FROM THE PATIENT’S PERSPECTIVE. A QUALITATIVE STUDY. | Prof. TAM Lai Shan |
| 2025.358 | Investigating the Predictive Power of Coronary Plaque for Major Adverse Cardiovascular Events (MACE) in Psoriatic Arthritis: A 10-year Retrospective Study | Prof. TAM Lai Shan |
| 2025.258 | Developing neural network based new methods for the detection and quantification of enthesiophytes and erosions in inflammatory arthritis diagnosis using high resolution peripheral quantitative computed tomography (HR-pQCT) images | Prof. TAM Lai Shan |
| 2025.432 | The First Phase Study to Evaluate the Safety of In-Vivo CAR-T Therapy for Patients with Refractory Systemic Lupus Erythematosus | Prof. Tam Lai Shan |
| 2025.866 | Erosion and joint space trajectories assessed using HR-pQCT in RA correlation with functional outcomes | Prof. TAM Lai Shan |
| 2023.633 | Defining active and structural lesions in the sacroiliac joint and spine by MRI and their predictive utility in axial psoriatic arthritis -a prospective study | Prof Tam Lai Shan |
| 2025.008 | A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-naïve Participants with Active Psoriatic Arthritis | Prof. TAM Lai Shan |
| 2024.193 | Lowest Efficacious Dose in Psoriatic Arthritis (LED PsA): A Multicentre Non-inferiority Randomized Open-Label Controlled Trial Assessing b/tsDMARDs Spacing | Prof. TAM Lai Shan |
| 2024.182 | Causal machine learning models for prediction of serious infection events in inflammatory arthritis: a population-based study |
Prof. TAM Lai Shan Lai Shan TAM |
| 2025.019 | Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of JNJ-77242113 for the Treatment of Biologic-experienced and Biologic-naïve Participants with Active Psoriatic Arthritis | Prof. TAM Lai Shan |
| 2015.065 | Phase 3b/4 Randomized Safety Endpoint Study Of 2 Doses Of Tofacitinib In Comparison To A Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | Prof. TAM Lai Shan |
| 2017.295 | The long term renal outcome of biopsy proven paediatric lupus nephritis - a comparison of local and overseas cohort |
Prof. TAM Lai Shan 譚麗珊 |
| 2014.343 | Adaptation and validation of the Ankylosing Spondylitis Quality of Life (ASQOL) and Psoriatic Arthritis Quality of Life (PsAQOL) questionnaires in Hong Kong | Prof. TAM Lai Shan |
| 2016.366 | MicroRNAs as biomarkers for predicting the effect of anti-TNF and anti-IL6 in changes of bone erosions in rheumatoid arthritis using HR-pQCT |
Prof. TAM Lai Shan 譚麗珊 |
| 2017.239 | The Hong Kong Psoriatic Arthritis Screening program | Prof. TAM Lai Shan |
| 2015.334 | Characterization of the potential role of interleukin-36 (IL-36) in regulating protective and pathogenic B cells in systemic lupus erythematosus |
Dr. TAM Lai Shan 譚麗珊 |
Page 72 of 289.